Latest Announcements

TPL Plastech Limited has reported its unaudited Consolidated Financial Results for the quarter and half year ended 30th September, 2026, with a 15% YoY volume growth, 39.9% YoY revenue growth, and 16.7% YoY EBITDA growth.

Aurobindo Pharma Ltd has announced its financial results for the quarter and half year ended September 30, 2026, with a standalone profit after tax from continuing operations of Rs. 7,235.8 million. The company has also declared an interim dividend of 700% and approved the re-appointment of a director.

Vindhya Telelinks Ltd reported an 82% growth in quarterly net profit driven by strong cable-led performance, with continued focus on EPC cash flow recovery, operational efficiency, and disciplined growth.

Vindhya Telelinks Limited reported an 82% growth in quarterly net profit driven by strong cable-led performance, with continued focus on EPC cash flow recovery, operational efficiency, and disciplined growth.

NRB Bearing Limited has announced its unaudited financial results for the quarter ended September 30, 2026, and declared an interim dividend of Rs. 2.50 per equity share. The company also announced the reconstitution of its Nomination and Remuneration Committee and adopted new policies, including a Sustainability Policy and a Biodiversity Policy.

Galaxy Surfactants Ltd has announced its unaudited financial results for the quarter and half-year ended September 30, 2026, along with an interim dividend of Rs.18 per equity share, re-appointment of Managing Director, change in Company Secretary, and appointment of Statutory Auditors.

Aurobindo Pharma Ltd has announced the declaration of an interim dividend of 700% for FY 2026-2027, with a record date of November 11, 2026, and payment date of November 20, 2026.

V2 Retail Limited has entered into a long-term strategic retail partnership with Cupid Limited, a growing player in the personal care, wellness and consumer healthcare segment, across 425+ stores.

V2 Retail Limited has entered into a long-term strategic retail partnership with Cupid Limited, a growing player in the personal care, wellness and consumer healthcare segment. The partnership will provide Cupid Limited with 400 square feet of dedicated retail space across V2 Retail's existing network of over 425 stores, as well as all future stores opened by the Company.

Aurobindo Pharma Ltd has declared an interim dividend of 700% for FY 2026-27, with a record date of November 11, 2026, and payment date of November 20, 2026.

Entero Healthcare Solutions Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with a net profit of Rs. 191.44 crore and a revenue from operations of Rs. 1,145.71 crore.

Aurobindo Pharma Limited has declared an interim dividend of 700% i.e. Rs. 7.00 per equity share, with a record date of November 11, 2026, and payment on or before November 20, 2026.

Golkunda Diamonds & Jewellery Ltd has announced its unaudited financial results for Q2 and H1 FY27, showing a 113.23% and 88.76% YoY PAT growth respectively. The company has also established a new brand, NIBHANA, exclusively focused on lab-grown diamond jewellery, with four retail stores already operational and plans to establish seven more in the near future.

Aurobindo Pharma Limited has released its investor presentation for Q2FY27, highlighting a 23.9% year-over-year revenue growth to ₹10,263 Cr, driven by strong performance across all business areas, with a highest-ever quarterly EBITDA of ₹2,156 Cr and a net profit of ₹1,124 Cr.

Stove Kraft Ltd has announced its Q2 & H1 FY27 investor presentation, highlighting operational highlights, including highest ever EBIDTA % of 12.9% for Q2 FY27, revenue growth of 23.2% YoY, and strong operating and financial leverage driving EBITDA and PAT growth.

Aurobindo Pharma Limited has announced its consolidated financial results for the quarter ended September 30, 2026, with revenue from operations increasing by 24% YoY to INR 10,263 Cr, driven by growth across businesses.

Krishna Institute of Medical Sciences Ltd has announced its unaudited financial results for the 2nd quarter and half-year ended 30th September 2026, showing a growth of 41.3% in total revenue and 34.0% in EBITDA on a year-on-year basis.

Godavari Biorefineries Ltd reported Q2 FY27 results, with total revenue of Rs. 549.8 Cr and EBITDA of Rs. 10.9 Cr, a turnaround from Q2 FY26's negative EBITDA. The Bio-based Chemicals business saw strong growth, with revenue up 39% YoY and segment EBITDA increasing by 47% YoY.

Godavari Biorefineries Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026, showing a turnaround in quarterly performance despite industry headwinds. The company's Bio-based Chemicals business maintained strong momentum, with revenue growing by approximately 39% year-on-year and segment EBITDA increasing by approximately 47% year-on-year.

Aurobindo Pharma Ltd has announced its Q2 FY27 financial results, with revenue of ₹10,263 Cr, a 23.9% growth YoY, and highest-ever quarterly EBITDA of ₹2,156 Cr at a margin of 21.0%. The company has also launched 10 products in the US market and generated net cash flow of US$ 146mn during the quarter.